drugset / Trial / NCT00022360
Taurolidine in Treating Patients With Recurrent or Progressive Glioma
Treatment
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of taurolidine in treating patients who have recurrent or progressive glioma.
Timeline
- Start
- 2001-05
- Primary completion
- 2001-10
- Completion
- 2001-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | taurolidine | Small molecule | — | Intravenous |